Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
FLORHAM PARK, N.J., Jan. 31, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq:PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Wednesday, February 7, 2024, at 1:30 p.m. ET.
Related news for (PHAT)
- Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates
- 24/7 Market News Snapshot 07 August, 2025 – Phathom Pharmaceuticals, Inc. Common Stock (NASDAQ:PHAT)
- Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
- Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032
- 24/7 Market News Snapshot 06 June, 2025 – Phathom Pharmaceuticals, Inc. Common Stock (NASDAQ:PHAT)
